Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing
- PMID: 18249390
- DOI: 10.1016/j.fertnstert.2007.10.069
Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing
Abstract
Objective: To report preferences of recipient couples for genetic testing of their oocyte donors.
Design: Observational report of results from a genetic testing-options form implemented as part of routine care.
Setting: Private practice.
Patient(s): Recipients and oocyte donors.
Intervention(s): Recipient couples completed a form before screening of their oocyte donor that outlined required screening and recommended tests that the couple could accept or decline. Couples were given information about carrier frequency, risk to their child if results were abnormal, and cost.
Main outcome measure(s): Percentage of couples accepting optional testing.
Result(s): Of the 63 couples with data available from their first testing-options form, 42 (67%) accepted and 21 (33%) declined fragile X testing, whereas 34 (54%) accepted and 29 (46%) declined karyotyping. When asked whether they would accept additional testing of their donor if it was recommended by a genetic counselor, 15 (24%) said that they would accept additional testing regardless of cost, 35 (56%) declined, and 13 (20%) indicated that their decision would depend on the cost. In many cases, history was elicited by the genetic counselor or test results were obtained that influenced further testing, decisions to proceed, or provided information important for the child.
Conclusion(s): Recipient couples sometimes chose to decline tests that we recommended but did not require, despite the relatively low cost of this testing compared with the total cost of the oocyte donation cycle.
Similar articles
-
A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis.Fertil Steril. 2010 Apr;93(6):1793-804. doi: 10.1016/j.fertnstert.2008.12.053. Epub 2009 May 12. Fertil Steril. 2010. PMID: 19439290
-
Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington's disease.Fertil Steril. 2006 Mar;85(3):597-602. doi: 10.1016/j.fertnstert.2005.08.050. Fertil Steril. 2006. PMID: 16500325
-
How do patient perceived determinants influence the decision-making process to accept or decline preimplantation genetic screening?Fertil Steril. 2016 Jan;105(1):188-93. doi: 10.1016/j.fertnstert.2015.09.022. Epub 2015 Oct 24. Fertil Steril. 2016. PMID: 26474735
-
Genetic screening and counseling.Curr Opin Obstet Gynecol. 2008 Apr;20(2):157-63. doi: 10.1097/GCO.0b013e3282f73230. Curr Opin Obstet Gynecol. 2008. PMID: 18388816 Review.
-
Screening for single gene genetic disease.Gynecol Obstet Invest. 2005;60(1):19-26. doi: 10.1159/000083481. Epub 2005 Feb 24. Gynecol Obstet Invest. 2005. PMID: 15731563 Review.
Cited by
-
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.Ont Health Technol Assess Ser. 2023 Aug 10;23(4):1-398. eCollection 2023. Ont Health Technol Assess Ser. 2023. PMID: 37637488 Free PMC article.
-
Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases.PLoS Curr. 2012 May 2;4:e4f9877ab8ffa9. doi: 10.1371/4f9877ab8ffa9. PLoS Curr. 2012. PMID: 22872815 Free PMC article.
-
Carrier testing for severe childhood recessive diseases by next-generation sequencing.Sci Transl Med. 2011 Jan 12;3(65):65ra4. doi: 10.1126/scitranslmed.3001756. Sci Transl Med. 2011. PMID: 21228398 Free PMC article.
-
Keeping clinicians in clinical research: the Clinical Research/Reproductive Scientist Training Program.Fertil Steril. 2009 Mar;91(3):664-6. doi: 10.1016/j.fertnstert.2008.10.029. Epub 2009 Jan 14. Fertil Steril. 2009. PMID: 19144332 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical